Santori & Peters Inc’s AMAG Pharmaceuticals AMAG Stock Holding History

Santori & Peters Inc’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$2K	–	592
2017 Q4	$2K	Buy	+200	New	+$3.02K	﹤0.01%	578

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Santori & Peters Inc's AMAG Position: Q1 2018 in Review

Santori & Peters Inc sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 200 shares — an estimated $2K sold.

Santori & Peters Inc first reported a position in AMAG in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

Santori & Peters Inc reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 200 AMAG Pharmaceuticals shares in Q1 2018, an estimated $2K.
Santori & Peters Inc first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's AMAG Pharmaceuticals position peaked at $2K in Q4 2017.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.